FDA approval of Istodax for cutaneous T-cell lymphoma.

Journal of Drugs in DermatologyVol. 9 Nbr. 2, February 2010

Linked as:

Summary


PIPELINE PREVIEWS

See the full content of this document

Extract


FDA approval of Istodax for cutaneous T-cell lymphoma.

Gloucester Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) to start marketing Istodax[R] (ro...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company